BREWIN DOLPHIN LTD - DELMAR PHARMACEUTICALS INC ownership

DELMAR PHARMACEUTICALS INC's ticker is DMPI and the CUSIP is 247078306. A total of 12 filers reported holding DELMAR PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of DELMAR PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$20,634
+72.7%
30,0000.0%0.00%
+100.0%
Q1 2020$11,946
-42.3%
30,0000.0%0.00%
-50.0%
Q4 2019$20,69130,0000.00%
Other shareholders
DELMAR PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,226,022$153,0000.04%
FNY Investment Advisers, LLC 47,000$32,0000.01%
Virtu Financial LLC 66,038$46,0000.00%
BREWIN DOLPHIN LTD 30,000$20,6910.00%
BARCLAYS PLC 89,488$62,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 4,000$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DEUTSCHE BANK AG\ 14,000$9,0000.00%
MORGAN STANLEY 250$00.00%
BANK OF MONTREAL /CAN/ 427$00.00%
View complete list of DELMAR PHARMACEUTICALS INC shareholders